Mycophenolate Mofetil in the Treatment of Chronic Non-infectious, Non-necrotizing Scleritis

REFERENCES

• Albini TA, Rao NA, Smith RE. The diagnosis and management of anterior scleritis. Int Ophthalmol Clin. 2005;45:191–204.
   PubMedGoogle Scholar
• Akpek EK, Uy HS, Christen W, et al. Severity of episcleritis and systemic disease association. Ophthalmology. 1999;106:729–731.
   PubMed Web of Science ®Google Scholar
• Riono WP, Hidayat AA, Rao NA. Scleritis: A clinicopathologic study of 55 cases. Ophthalmology. 1999;106:1328–1333.
   PubMed Web of Science ®Google Scholar
• Jachens AW, Chu DS. Retrospective review of methotrexate therapy in the treatment of chronic, noninfectious, nonnecrotizing scleritis. Am J Ophthalmol. 2008 Mar;145(3):487–492.
   PubMedGoogle Scholar
• Pras E, Neumann R, Zandman-Goddard G, et al. Intraocular inflammation in autoimmune diseases. Semin Arthritis Rheum. 2004;34:602–609.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Mudun A, Dunn JP, et al. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130:469–476.
   PubMed Web of Science ®Google Scholar
• Reed MD, Chu DS. Immunomodulatory therapy for anterior segment ocular inflammation. Curr Opin in Allergy Clin Immunol. 2002;2:429–433.
   PubMedGoogle Scholar
• Lustig MJ, Cunningham ET. Use of immunosuppressive agents in uveitis. Curr Opin Ophthalmol. 2003;14:399–412.
   PubMedGoogle Scholar
• Gaudio PA. A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation. Ocul Immunol Inflamm. 2004;12:169–192.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000;130:492–513.
   PubMed Web of Science ®Google Scholar
• Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation. 1995 Aug 15;60(3):225–232.
   PubMedGoogle Scholar
• Baltatzis S, Tufail F, Yu EN, et al. Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology. 2003 May;110(5);1061–1065.
   PubMed Web of Science ®Google Scholar
• Kilmartin DJ, Forrester JV, Dick AD. Rescue therapy with mycophenolate mofetil in refractory uveitis. Lancet. 1998 Jul 4;352(9121):35–36.
   PubMed Web of Science ®Google Scholar
• Sen HN, Suhler EB, Al-Khatib SQ, et al. Mycophenolate mofetil for the treatment of scleritis. Ophthalmology. 2003;110:1750–1755.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Jabs DA, Qazi FA, et al. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology. 2005;112:1472–1477.
   PubMed Web of Science ®Google Scholar
• Siepmann K, Huber M, Stubiger N, et al. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis; a retrospective analysis of 106 patients. Graefes Arch Clin Exp Ophthalmol. 2006 Jul;244(7):799–794.
   Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005 Sep;140(3):509–516.
   PubMed Web of Science ®Google Scholar
• Lipsky JJ. Mycophenolate mofetil. Lancet 1996;348:1357–1359.
   PubMed Web of Science ®Google Scholar
• Nagy SE, Andersson JP, Andersson UG. Effect of mycophenolate mofetil (RS-61443) on cytokine production: inhibition of superantigen-induced cytokines. Immunopharmacology. 1993;26:11–20.
   PubMed Web of Science ®Google Scholar
• Allison AC, Eugui EM. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clinical Transplantation. 1996;10:77–84.
   PubMed Web of Science ®Google Scholar
• Sobrin L, Christen W, Foster CS. Mycophenolate Mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Ophthalmology. 2008:115: 1416–1421.
   PubMed Web of Science ®Google Scholar
• Daniel E, Thorne JE, Newcomb CW, et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010 Mar;149(3):423–432. e1–2.
   PubMedGoogle Scholar
• Rathore VM, Agrawal R, Chaudhary SP, et al. Mycophenolate mofetil therapy in uveitis: analysis of eight cases in a tertiary ophthalmic care centre in India. Int Ophthalmol. 2009 Apr;29(2):117–122.
   PubMedGoogle Scholar
• Neri P, Mariotti C, Cimino L, et al. Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil. Int Ophthalmol. 2009 Jun;29(3):127–133.
   PubMedGoogle Scholar
• Neri P, Manoni M, Fortuna C, et al. Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunosuppressants: interventional case series. Int Ophthalmol. 2010 Oct;30(5):583–590.
   PubMedGoogle Scholar
• Patel AK, Hoch S, Shindler KS. Mycophenolate mofetil treatment of steroid-resistant idiopathic sclerosing orbital inflammation. Clin Experiment Ophthalmol. 2011 Dec;39(9):912–913.
   PubMedGoogle Scholar
• Chang PY, Giuliari GP, Shaikh M, et al. Mycophenolate mofetil monotherapy in the management of paediatric uveitis. Eye (Lond). 2011 Apr;25(4):427–435.
   PubMedGoogle Scholar
• Doycheva D, Deuter C, Blumenstock G, et al. Long-term Results of Therapy with Mycophenolate Mofetil in Ocular Mucous Membrane Pemphigoid. Ocul Immunol Inflamm. 2011 Dec;19(6):431–438.
   PubMedGoogle Scholar
• Daniel E, Thorne JE, Newcomb CW, et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010 Mar;149(3):423–432. e1–2
   PubMedGoogle Scholar
• Bhat P, Cervantes-Castañeda RA, Doctor PP, et al. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm. 2009 May-Jun;17(3):185–190.
   PubMedGoogle Scholar